Biocartis

Generaal De Wittelaan 11

2800 Mechelen

BE

Biocartis

Foundation date

02/07/2010

Sector

#Medical Technology

Subsector

Therapeutic areas

Biocartis is an innovative molecular diagnostics company committed to revolutionize molecular testing with its unique proprietary IdyllaTM platform. We provide next generation diagnostic solutions aimed at improving clinical practice for the benefit of patients, clinicians, payers and the healthcare industry, with a focus on oncology.

Biocartis’ proprietary molecular diagnostics (MDx) IdyllaTM platform is a fully automated sample-to-result, real-time PCR system that offers accurate, highly reliable molecular information from virtually any biological sample, in virtually any setting, allowing fast and effective treatment selection and treatment progress monitoring.

Upcoming events

Latest news

  • UCB announces positive Phase 3 studies for bimekizumab in hidradenitis suppurativa

    1 day ago

  • Company growth prompts Connected-Pathology relocation to larger laboratory facilities to accommodate increase in study capacity

    Tuesday December 6th 2022

  • Japan welcomes companies, startups and knowledge institutions from Flanders

    Friday December 2nd 2022

Jobs by Biocartis